fluorouracil and vanoxerine

fluorouracil has been researched along with vanoxerine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chen, R; Dong, C; Gu, P; Jiang, BH; Ke, KB; Leung, KS; Li, HJ; Lin, MC; Lu, G; Qiu, JG; Shi, XN; Su, R; Wang, L; Wong, MH; Wu, SG; Xia, ZK; Zhang, JY; Zhao, H; Zhou, FM; Zhu, Y1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J1

Other Studies

3 other study(ies) available for fluorouracil and vanoxerine

ArticleYear
Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinoma.
    Molecular medicine (Cambridge, Mass.), 2021, 02-12, Volume: 27, Issue:1

    Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Down-Regulation; Drug Synergism; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Injections, Subcutaneous; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Piperazines; Xenograft Model Antitumor Assays

2021
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
    Nature chemical biology, 2009, Volume: 5, Issue:10

    Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection

2009